180 related articles for article (PubMed ID: 12177805)
1. Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.
Luo LY; Herrera I; Soosaipillai A; Diamandis EP
Br J Cancer; 2002 Jul; 87(3):339-43. PubMed ID: 12177805
[TBL] [Abstract][Full Text] [Related]
2. [Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):834-9. PubMed ID: 18476518
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
[TBL] [Abstract][Full Text] [Related]
4. An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients.
Vidal CI; Mintz PJ; Lu K; Ellis LM; Manenti L; Giavazzi R; Gershenson DM; Broaddus R; Liu J; Arap W; Pasqualini R
Oncogene; 2004 Nov; 23(55):8859-67. PubMed ID: 15480432
[TBL] [Abstract][Full Text] [Related]
5. The construction of cDNA library and the screening of related antigen of ascitic tumor cells of ovarian cancer.
Hou Q; Chen K; Shan Z
Eur J Gynaecol Oncol; 2015; 36(5):590-4. PubMed ID: 26513889
[TBL] [Abstract][Full Text] [Related]
6. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
7. A block in the road to fertility: autoantibodies to heat-shock protein 90-beta in human ovarian autoimmunity.
Pires ES; Khole VV
Fertil Steril; 2009 Oct; 92(4):1395-1409. PubMed ID: 19022436
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.
Taylor DD; Gercel-Taylor C; Parker LP
Gynecol Oncol; 2009 Oct; 115(1):112-120. PubMed ID: 19647308
[TBL] [Abstract][Full Text] [Related]
10. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
11. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
12. Multiple serological biomarkers for colorectal cancer detection.
Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
[TBL] [Abstract][Full Text] [Related]
13. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q.
Stone B; Schummer M; Paley PJ; Thompson L; Stewart J; Ford M; Crawford M; Urban N; O'Briant K; Nelson BH
Int J Cancer; 2003 Mar; 104(1):73-84. PubMed ID: 12532422
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
Kim S; Cho H; Nam EJ; Kim SW; Kim YT; Park YW; Kim BW; Kim JH
Genes Chromosomes Cancer; 2010 Jul; 49(7):585-95. PubMed ID: 20461751
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.
Shi L; Chevolot Y; Souteyrand E; Laurenceau E
Cancer Biomark; 2017; 18(2):105-116. PubMed ID: 27983529
[TBL] [Abstract][Full Text] [Related]
16. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
17. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
18. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.
Lokshin AE; Winans M; Landsittel D; Marrangoni AM; Velikokhatnaya L; Modugno F; Nolen BM; Gorelik E
Gynecol Oncol; 2006 Aug; 102(2):244-51. PubMed ID: 16434085
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody biomarkers for the detection of serous ovarian cancer.
Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.
Grandjean M; Sermeus A; Branders S; Defresne F; Dieu M; Dupont P; Raes M; De Ridder M; Feron O
PLoS One; 2013; 8(10):e76508. PubMed ID: 24130777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
